Features of the bronchial bacterial microbiome associated with atopy, asthma, and responsiveness to inhaled corticosteroid treatment

Study information

EditHistoryDelete

Flag for review

Your review change was submittedAdd a new Experiment

• Quality control
  • Retracted paper
  • Contamination issues suspected
  • Batch effect issues suspected
  • Uncontrolled confounding suspected
  • Results are suspect (various reasons)
  • Apply tags

    Tags applied

Reviewed Marked as Reviewed by Claregrieve1 on 2022/11/13

study design

cross-sectional observational, not case-control

Citation

PMID PubMed identifier for scientific articles.

27838347

DOI Digital object identifier for electronic documents.

10.1016/j.jaci.2016.08.055

URI

Authors

Durack J, Lynch SV, Nariya S, Bhakta NR, Beigelman A, Castro M, Dyer AM, Israel E, Kraft M, Martin RJ, Mauger DT, Rosenberg SR, Sharp-King T, White SR, Woodruff PG, Avila PC, Denlinger LC, Holguin F, Lazarus SC, Lugogo N, Moore WC, Peters SP, Que L, Smith LJ, Sorkness CA, Wechsler ME, Wenzel SE, Boushey HA, Huang YJ

Journal

The Journal of allergy and clinical immunology

Year

2017

Keywords:

16S ribosomal RNA, Asthma, T(H)2 inflammation, atopy, bacteria, corticosteroids, metabolic pathways, microbiome, short-chain fatty acids, three-gene mean

BACKGROUND: Compositional differences in the bronchial bacterial microbiota have been associated with asthma, but it remains unclear whether the findings are attributable to asthma, to aeroallergen sensitization, or to inhaled corticosteroid treatment. OBJECTIVES: We sought to compare the bronchial bacterial microbiota in adults with steroid-naive atopic asthma, subjects with atopy but no asthma, and nonatopic healthy control subjects and to determine relationships of the bronchial microbiota to phenotypic features of asthma. METHODS: Bacterial communities in protected bronchial brushings from 42 atopic asthmatic subjects, 21 subjects with atopy but no asthma, and 21 healthy control subjects were profiled by using 16S rRNA gene sequencing. Bacterial composition and community-level functions inferred from sequence profiles were analyzed for between-group differences. Associations with clinical and inflammatory variables were examined, including markers of type 2-related inflammation and change in airway hyperresponsiveness after 6 weeks of fluticasone treatment. RESULTS: The bronchial microbiome differed significantly among the 3 groups. Asthmatic subjects were uniquely enriched in members of the Haemophilus, Neisseria, Fusobacterium, and Porphyromonas species and the Sphingomonodaceae family and depleted in members of the Mogibacteriaceae family and Lactobacillales order. Asthma-associated differences in predicted bacterial functions included involvement of amino acid and short-chain fatty acid metabolism pathways. Subjects with type 2-high asthma harbored significantly lower bronchial bacterial burden. Distinct changes in specific microbiota members were seen after fluticasone treatment. Steroid responsiveness was linked to differences in baseline compositional and functional features of the bacterial microbiome. CONCLUSION: Even in subjects with mild steroid-naive asthma, differences in the bronchial microbiome are associated with immunologic and clinical features of the disease. The specific differences identified suggest possible microbiome targets for future approaches to asthma treatment or prevention.

Experiment 1

EditHistoryDelete

Flag for review

Your review change was submittedDuplicate this ExperimentAdd a new Signature

Reviewed Marked as Reviewed by Claregrieve1 on 2022/11/13

Curated date: 2021/01/10

Curator: WikiWorks

Revision editor(s): Claregrieve1, WikiWorks, ChiomaBlessing

Subjects

Location of subjects

United States of America

Host species Species from which microbiome was sampled. Contact us to have more species added.

Homo sapiens

Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology

Bronchus Bronchi,Bronchial tissue,Bronchial trunk,Bronchus,bronchus

Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology

Atopic asthma allergic asthma,Atopic asthma,atopic asthma

Group 0 name Corresponds to the control (unexposed) group for case-control studies

healthy control

Group 1 name Corresponds to the case (exposed) group for case-control studies

atopic asthma

Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group

Patients who have atopic asthma

Group 0 sample size Number of subjects in the control (unexposed) group

21

Group 1 sample size Number of subjects in the case (exposed) group

42

Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)

3 months

Lab analysis

Sequencing type

16S

16S variable region One or more hypervariable region(s) of the bacterial 16S gene

V4

Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance

Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).

raw counts

Statistical test

Negative Binomial Regression

Significance threshold p-value or FDR threshold used for differential abundance testing (if any)

0.1

MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?

Yes

Alpha Diversity

Pielou Quantifies how equal the community is numerically

unchanged

Shannon Estimator of species richness and species evenness: more weight on species richness

unchanged

Richness Number of species

unchanged

Signature 1

EditHistoryDelete

Flag for review

Your review change was submitted

Reviewed Marked as Reviewed by Claregrieve1 on 2022/11/13

Curated date: 2021/01/10

Curator: Lucy Mellor

Revision editor(s): Claregrieve1, WikiWorks

Source: Figure 2a, Supplemental Table S4

Description: Differentially abundant microbial taxa in atopic asthmatic (AA) subjects compared with healthy controls (HC)

Abundance in Group 1: increased abundance in atopic asthma

NCBI	Quality Control	Links
Actinomyces
Alloprevotella tannerae
Anaerovorax
Campylobacter
Fusobacterium
Haemophilus
Kingella
Lactobacillus iners
Neisseria
Neisseria subflava
Porphyromonas
Prevotella
Segatella copri
Sphingopyxis
Sphingopyxis alaskensis
Treponema
Treponema amylovorum
Veillonella
Veillonella dispar

Revision editor(s): Claregrieve1, WikiWorks

Signature 2

EditHistoryDelete

Flag for review

Your review change was submitted

Reviewed Marked as Reviewed by Claregrieve1 on 2022/11/13

Curated date: 2021/01/10

Curator: Lucy Mellor

Revision editor(s): Claregrieve1, WikiWorks

Source: Figure 2a, Supplemental Table S4

Description: Differential microbial abundance between atopic asthmatic (AA) subjects compared with healthy controls (HC)

Abundance in Group 1: decreased abundance in atopic asthma

NCBI	Quality Control	Links
Actinobacillus
Kocuria palustris
Lacticaseibacillus zeae
Lactobacillus
Leptotrichia
Methylobacterium
Peptostreptococcus

Revision editor(s): Claregrieve1, WikiWorks

Experiment 2

EditHistoryDelete

Flag for review

Your review change was submittedDuplicate this ExperimentAdd a new Signature

Reviewed Marked as Reviewed by Claregrieve1 on 2022/11/13

Curated date: 2021/01/10

Curator: WikiWorks

Revision editor(s): Claregrieve1, WikiWorks, ChiomaBlessing

Differences from previous experiment shown

Subjects

Group 1 name Corresponds to the case (exposed) group for case-control studies

atopic no asthma

Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group

atopic nonasthmatic subjects

Group 1 sample size Number of subjects in the case (exposed) group

21

Lab analysis

Statistical Analysis

Alpha Diversity

Pielou Quantifies how equal the community is numerically

unchanged

Shannon Estimator of species richness and species evenness: more weight on species richness

unchanged

Richness Number of species

unchanged

Signature 1

EditHistoryDelete

Flag for review

Your review change was submitted

Reviewed Marked as Reviewed by Claregrieve1 on 2022/11/13

Curated date: 2021/01/10

Curator: Lucy Mellor

Revision editor(s): Claregrieve1, WikiWorks

Source: Figure 2b, Supplemental Table S5

Description: Differential microbial abundance between atopic nonasthmatic (ANA) subjects compared with healthy controls (HC)

Abundance in Group 1: increased abundance in atopic no asthma

NCBI	Quality Control	Links
Actinomyces
Aggregatibacter
Aggregatibacter segnis
Corynebacterium
Flexispira
Fusobacterium
Granulicatella
Haemophilus
Haemophilus influenzae
Moraxella
Prevotella melaninogenica
Hoylesella nanceiensis
Selenomonas
Sharpea
Sphingopyxis
Sphingopyxis alaskensis
Treponema amylovorum
Veillonella
Veillonella dispar

Revision editor(s): Claregrieve1, WikiWorks

Signature 2

EditHistoryDelete

Flag for review

Your review change was submitted

Reviewed Marked as Reviewed by Claregrieve1 on 2022/11/13

Curated date: 2021/01/10

Curator: Lucy Mellor

Revision editor(s): Claregrieve1, WikiWorks

Source: Figure 2b, Supplemental Table S5

Description: Differential microbial abundance between atopic nonasthmatic (ANA) subjects compared with healthy controls (HC)

Abundance in Group 1: decreased abundance in atopic no asthma

NCBI	Quality Control	Links
Helicobacter
Lacticaseibacillus zeae
Lactobacillus
Leptotrichia
Parvimonas
Porphyromonas
Prevotella
Pseudomonas
Streptococcus

Revision editor(s): Claregrieve1, WikiWorks

Experiment 3

EditHistoryDelete

Flag for review

Your review change was submittedDuplicate this ExperimentAdd a new Signature

Reviewed Marked as Reviewed by Claregrieve1 on 2022/11/13

Curated date: 2021/01/10

Curator: WikiWorks

Revision editor(s): Claregrieve1, WikiWorks, ChiomaBlessing

Differences from previous experiment shown

Subjects

Group 0 name Corresponds to the control (unexposed) group for case-control studies

atopic no asthma

Group 1 name Corresponds to the case (exposed) group for case-control studies

atopic asthma

Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group

atopic asthma subjects

Group 1 sample size Number of subjects in the case (exposed) group

42

Lab analysis

Statistical Analysis

Alpha Diversity

Pielou Quantifies how equal the community is numerically

unchanged

Shannon Estimator of species richness and species evenness: more weight on species richness

unchanged

Richness Number of species

unchanged

Signature 1

EditHistoryDelete

Flag for review

Your review change was submitted

Reviewed Marked as Reviewed by Claregrieve1 on 2022/11/13

Curated date: 2021/01/10

Curator: Lucy Mellor

Revision editor(s): Claregrieve1, WikiWorks

Source: Figure 2c, Supplemental Table S6

Description: Differential microbial abundance between atopic asthmatic (AA) subjects compared with atopic nonasthmatic (ANA) subjects

Abundance in Group 1: increased abundance in atopic asthma

NCBI	Quality Control	Links
Dialister
Fusobacterium
Haemophilus
Leptotrichia
Mycoplasma
Neisseria subflava
Prevotella
Prevotella intermedia
Selenomonas

Revision editor(s): Claregrieve1, WikiWorks

Signature 2

EditHistoryDelete

Flag for review

Your review change was submitted

Reviewed Marked as Reviewed by Claregrieve1 on 2022/11/13

Curated date: 2021/01/10

Curator: Lucy Mellor

Revision editor(s): Claregrieve1, WikiWorks

Source: Figure 2c, Supplemental Table S6

Description: Differential microbial abundance between atopic asthmatic (AA) subjects compared with atopic nonasthmatic (ANA) subjects

Abundance in Group 1: decreased abundance in atopic asthma

NCBI	Quality Control	Links
Aggregatibacter
Aggregatibacter segnis
Allobaculum
Bacteroides fragilis
Capnocytophaga ochracea
Corynebacterium
Flavobacterium columnare
Flexispira
Haemophilus influenzae
Haemophilus parainfluenzae
Lacticaseibacillus zeae
Lactobacillus
Porphyromonas
Segatella copri
Hoylesella nanceiensis
Sharpea
Sphingopyxis
Sphingopyxis alaskensis
Streptococcus
Treponema amylovorum
Mediterraneibacter gnavus

Revision editor(s): Claregrieve1, WikiWorks

Experiment 4

EditHistoryDelete

Flag for review

Your review change was submittedDuplicate this ExperimentAdd a new Signature

Reviewed Marked as Reviewed by Claregrieve1 on 2022/11/14

Curated date: 2021/01/10

Curator: WikiWorks

Revision editor(s): Claregrieve1, WikiWorks, ChiomaBlessing

Differences from previous experiment shown

Subjects

Group 0 name Corresponds to the control (unexposed) group for case-control studies

nonresponder

Group 1 name Corresponds to the case (exposed) group for case-control studies

inhaled corticosteroid responder

Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group

inhaled corticosteroid (ICS) responder

Group 0 sample size Number of subjects in the control (unexposed) group

10

Group 1 sample size Number of subjects in the case (exposed) group

15

Lab analysis

Statistical Analysis

Signature 1

EditHistoryDelete

Flag for review

Your review change was submitted

Reviewed Marked as Reviewed by Claregrieve1 on 2022/11/14

Curated date: 2021/01/10

Curator: Lucy Mellor

Revision editor(s): Claregrieve1, WikiWorks, Merit

Source: Figure 6b

Description: Differential relative taxon abundance in inhaled corticosteroid (ICS) responders versus nonresponders among those with atopic asthma

Abundance in Group 1: increased abundance in inhaled corticosteroid responder

NCBI	Quality Control	Links
Streptococcaceae
Erysipelotrichaceae
Fusobacteriaceae
Lachnospiraceae
Moraxellaceae
Neisseriaceae
Peptostreptococcaceae
Sphingomonadaceae
Veillonellaceae
unclassified Mogibacterium
Streptococcus

Revision editor(s): Claregrieve1, WikiWorks, Merit

Signature 2

EditHistoryDelete

Flag for review

Your review change was submitted

Reviewed Marked as Reviewed by Claregrieve1 on 2022/11/14

Curated date: 2021/01/10

Curator: Lucy Mellor

Revision editor(s): Claregrieve1, WikiWorks

Source: Figure 6b

Description: Differential relative taxon abundance in inhaled corticosteroid (ICS) responders versus nonresponders among those with atopic asthma

Abundance in Group 1: decreased abundance in inhaled corticosteroid responder

NCBI	Quality Control	Links
Actinomycetaceae
Aerococcaceae
Azotobacter group
Flavobacteriaceae
Lactobacillaceae
Microbacteriaceae
Mycoplasmataceae
Pasteurellaceae
Porphyromonadaceae
Prevotellaceae
Spirochaetaceae
Weeksellaceae
Gemella

Revision editor(s): Claregrieve1, WikiWorks

Experiment 5

EditHistoryDelete

Flag for review

Your review change was submittedDuplicate this ExperimentAdd a new Signature

Reviewed Marked as Reviewed by Claregrieve1 on 2022/11/14

Curated date: 2021/01/10

Curator: WikiWorks

Revision editor(s): Claregrieve1, WikiWorks, ChiomaBlessing

Differences from previous experiment shown

Subjects

Group 0 name Corresponds to the control (unexposed) group for case-control studies

baseline (corticosteroid treatment group)

Group 1 name Corresponds to the case (exposed) group for case-control studies

post inhaled corticosteroid treatment

Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group

asthma patients after inhaled corticosteroid treatment

Group 0 sample size Number of subjects in the control (unexposed) group

8

Group 1 sample size Number of subjects in the case (exposed) group

8

Lab analysis

Statistical Analysis

Signature 1

EditHistoryDelete

Flag for review

Your review change was submitted

Reviewed Marked as Reviewed by Claregrieve1 on 2022/11/14

Curated date: 2021/01/10

Curator: Lucy Mellor

Revision editor(s): WikiWorks

Source: Text, Figure 6d

Description: Taxa differentially expressed in asthmatic subjects who responded to treatment after inhaled corticosteroid (ICS) treatment

Abundance in Group 1: increased abundance in post inhaled corticosteroid treatment

NCBI	Quality Control	Links
Microbacteriaceae
Neisseria
Moraxella
Spirochaetaceae
Actinomycetaceae
Mycoplasmataceae

Revision editor(s): WikiWorks

Signature 2

EditHistoryDelete

Flag for review

Your review change was submitted

Reviewed Marked as Reviewed by Claregrieve1 on 2022/11/14

Curated date: 2021/01/10

Curator: Lucy Mellor

Revision editor(s): WikiWorks

Source: Text, Figure 6d

Description: Taxa differentially expressed in asthmatic subjects who responded to treatment after inhaled corticosteroid (ICS) treatment

Abundance in Group 1: decreased abundance in post inhaled corticosteroid treatment

NCBI	Quality Control	Links
Acholeplasmataceae
Lactobacillaceae
Prevotellaceae
Lachnospiraceae
Peptostreptococcaceae
Fusobacterium
Dialister

Revision editor(s): WikiWorks

Experiment 6

EditHistoryDelete

Flag for review

Your review change was submittedDuplicate this ExperimentAdd a new Signature

Reviewed Marked as Reviewed by Claregrieve1 on 2022/11/14

Curated date: 2021/01/10

Curator: WikiWorks

Revision editor(s): Claregrieve1, WikiWorks, ChiomaBlessing

Differences from previous experiment shown

Subjects

Group 0 name Corresponds to the control (unexposed) group for case-control studies

baseline (placebo group)

Group 1 name Corresponds to the case (exposed) group for case-control studies

post placebo treatment

Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group

placebo treatment

Lab analysis

Statistical Analysis

Signature 1

EditHistoryDelete

Flag for review

Your review change was submitted

Reviewed Marked as Reviewed by Claregrieve1 on 2022/11/14

Curated date: 2021/01/10

Curator: Lucy Mellor

Revision editor(s): WikiWorks

Source: Text, Figure 6d

Description: Taxa differentially expressed in asthmatic subjects after placebo treatment

Abundance in Group 1: increased abundance in post placebo treatment

NCBI	Quality Control	Links
Eikenella
Spirochaetaceae
Mycoplasmataceae

Revision editor(s): WikiWorks

Signature 2

EditHistoryDelete

Flag for review

Your review change was submitted

Reviewed Marked as Reviewed by Claregrieve1 on 2022/11/14

Curated date: 2021/01/10

Curator: Lucy Mellor

Revision editor(s): WikiWorks

Source: Text, Figure 6d

Description: Taxa differentially expressed in asthmatic subjects after placebo treatment

Abundance in Group 1: decreased abundance in post placebo treatment

NCBI	Quality Control	Links
Acinetobacter
Actinomycetaceae
Prevotellaceae
Peptostreptococcaceae

Revision editor(s): WikiWorks

Experiment 7

EditHistoryDelete

Flag for review

Your review change was submittedDuplicate this ExperimentAdd a new Signature

Reviewed Marked as Reviewed by Claregrieve1 on 2022/11/14

Curated date: 2021/01/10

Curator: WikiWorks

Revision editor(s): Claregrieve1, WikiWorks, ChiomaBlessing

Differences from previous experiment shown

Subjects

Group 0 name Corresponds to the control (unexposed) group for case-control studies

healthy control

Group 1 name Corresponds to the case (exposed) group for case-control studies

atopic asthma

Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group

atopic asthma subjects

Group 0 sample size Number of subjects in the control (unexposed) group

21

Group 1 sample size Number of subjects in the case (exposed) group

42

Lab analysis

Statistical Analysis

Alpha Diversity

Pielou Quantifies how equal the community is numerically

unchanged

Shannon Estimator of species richness and species evenness: more weight on species richness

unchanged

Richness Number of species

unchanged

Signature 1

EditHistoryDelete

Flag for review

Your review change was submitted

Reviewed Marked as Reviewed by Claregrieve1 on 2022/11/14

Curated date: 2021/01/10

Curator: Lucy Mellor

Revision editor(s): WikiWorks

Source: Supplemental Figure E4a

Description: Bacterial phylum significantly enriched or depleted in relative abundance in atopic asthmatic (AA) subjects compared with healthy controls (HC)

Abundance in Group 1: increased abundance in atopic asthma

NCBI	Quality Control	Links
Actinomycetota
Bacteroidota
Fusobacteriota
Pseudomonadota
Spirochaetota

Revision editor(s): WikiWorks

Signature 2

EditHistoryDelete

Flag for review

Your review change was submitted

Reviewed Marked as Reviewed by Claregrieve1 on 2022/11/14

Curated date: 2021/01/10

Curator: Lucy Mellor

Revision editor(s): WikiWorks

Source: Supplemental Figure E4a

Description: Bacterial phylum significantly enriched or depleted in relative abundance in atopic asthmatic (AA) subjects compared with healthy controls (HC)

Abundance in Group 1: decreased abundance in atopic asthma

NCBI	Quality Control	Links
Bacillota

Revision editor(s): WikiWorks

Experiment 8

EditHistoryDelete

Flag for review

Your review change was submittedDuplicate this ExperimentAdd a new Signature

Reviewed Marked as Reviewed by Claregrieve1 on 2022/11/14

Curated date: 2021/01/10

Curator: WikiWorks

Revision editor(s): Claregrieve1, WikiWorks, ChiomaBlessing

Differences from previous experiment shown

Subjects

Group 1 name Corresponds to the case (exposed) group for case-control studies

atopic no asthma

Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group

atopic no asthma

Group 1 sample size Number of subjects in the case (exposed) group

21

Lab analysis

Statistical Analysis

Alpha Diversity

Pielou Quantifies how equal the community is numerically

unchanged

Shannon Estimator of species richness and species evenness: more weight on species richness

unchanged

Richness Number of species

unchanged

Signature 1

EditHistoryDelete

Flag for review

Your review change was submitted

Reviewed Marked as Reviewed by Claregrieve1 on 2022/11/14

Curated date: 2021/01/10

Curator: Lucy Mellor

Revision editor(s): WikiWorks

Source: Supplemental Figure E4b

Description: Bacterial phylum significantly enriched or depleted in relative abundance in atopic nonasthmatic (ANA) subjects compared with healthy controls (HC)

Abundance in Group 1: increased abundance in atopic no asthma

NCBI	Quality Control	Links
Actinomycetota
Bacillota
Pseudomonadota

Revision editor(s): WikiWorks

Signature 2

EditHistoryDelete

Flag for review

Your review change was submitted

Reviewed Marked as Reviewed by Claregrieve1 on 2022/11/14

Curated date: 2021/01/10

Curator: Lucy Mellor

Revision editor(s): WikiWorks

Source: Supplemental Figure E4b

Description: Bacterial phylum significantly enriched or depleted in relative abundance in atopic nonasthmatic (ANA) subjects compared with healthy controls (HC)

Abundance in Group 1: decreased abundance in atopic no asthma

NCBI	Quality Control	Links
Bacteroidota
Fusobacteriota
Spirochaetota

Revision editor(s): WikiWorks

Experiment 9

EditHistoryDelete

Flag for review

Your review change was submittedDuplicate this ExperimentAdd a new Signature

Reviewed Marked as Reviewed by Claregrieve1 on 2022/11/14

Curated date: 2021/01/10

Curator: WikiWorks

Revision editor(s): Claregrieve1, WikiWorks, ChiomaBlessing

Differences from previous experiment shown

Subjects

Group 0 name Corresponds to the control (unexposed) group for case-control studies

atopic no asthma

Group 1 name Corresponds to the case (exposed) group for case-control studies

atopic asthma

Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group

atopic asthma subjects

Group 1 sample size Number of subjects in the case (exposed) group

42

Lab analysis

Statistical Analysis

Alpha Diversity

Pielou Quantifies how equal the community is numerically

unchanged

Shannon Estimator of species richness and species evenness: more weight on species richness

unchanged

Richness Number of species

unchanged

Signature 1

EditHistoryDelete

Flag for review

Your review change was submitted

Reviewed Marked as Reviewed by Claregrieve1 on 2022/11/14

Curated date: 2021/01/10

Curator: Lucy Mellor

Revision editor(s): WikiWorks

Source: Supplemental Figure E4c

Description: Bacterial phylum significantly enriched or depleted in relative abundance in atopic asthmatic (AA) subjects compared with atopic nonasthmatic (ANA)

Abundance in Group 1: increased abundance in atopic asthma

NCBI	Quality Control	Links
Bacteroidota
Fusobacteriota

Revision editor(s): WikiWorks

Signature 2

EditHistoryDelete

Flag for review

Your review change was submitted

Reviewed Marked as Reviewed by Claregrieve1 on 2022/11/14

Curated date: 2021/01/10

Curator: Lucy Mellor

Revision editor(s): WikiWorks

Source: Supplemental Figure E4c

Description: Bacterial phylum significantly enriched or depleted in relative abundance in atopic asthmatic (AA) subjects compared with atopic nonasthmatic (ANA)

Abundance in Group 1: decreased abundance in atopic asthma

NCBI	Quality Control	Links
Actinomycetota
Bacillota
Pseudomonadota
Spirochaetota

Revision editor(s): WikiWorks